Executive Ethics: Divestiture and Emoluments Enforcement for the Presidency

A disclosure duty with no divestiture duty behind it

Two statutes do two different jobs, and the space between them is the whole problem. Title I of the Ethics in Government Act of 1978, later amended by the STOCK Act of 2012, requires the President and Vice President to file an annual financial disclosure and to report securities transactions over $1,000 within 30 days of notice and 45 days of the trade. Those duties apply to the presidency, and the disclosures are public. Title 18's conflict-of-interest statute, 18 U.S.C. § 208, does a different job: it requires an official to step back from any government matter touching their own financial interest, backed by criminal liability. Section 202(c) exempts the President and Vice President from that duty by name, a choice Congress wrote into the Ethics Reform Act of 1989 after the Justice Department had already concluded, in a 1974 opinion on Nelson Rockefeller's vice-presidential nomination, that Section 208 was never meant to reach the President and could not be applied to the office without risking an unconstitutional constraint on Article II authority.

The result is a regime that requires the President to show the public a conflict without requiring the President to do anything about it. The disclosure covering President Trump's 2025 finances, certified by the Office of Government Ethics in 2026, shows what that looks like in practice: a periodic transaction report covering more than 3,600 first-quarter trades was filed with late fees attached, every transaction on it flagged as reported more than 30 days after notification, and licensing income from Trump-branded watches, sneakers, and fragrances described as "inadvertently omitted" from the prior year's filing. OGE can certify a disclosure like that. It cannot compel a correction or impose a penalty. Enforcement of the Ethics in Government Act's civil penalties, and of the federal false-statements statute where it might reach a disclosure filing, runs through the Justice Department, which the President appoints.

Extending a tool that already exists

Divestiture and blind trusts are not new instruments; this issue proposes extending one already in use. The Ethics in Government Act already defines a "qualified blind trust" at 5 U.S.C. § 13104(f) and 5 C.F.R. Part 2634, Subpart D, and cabinet officials use it today to satisfy Section 208: an independent trustee with no ties to the official takes sole control of the assets, with no reporting back and communications pre-screened by an ethics office. The fix here is not a new legal category. It is applying the category that already works to the two offices Congress carved out of it in 1989.

That distinction answers the strongest version of the constitutional objection. The 1974 position was about recusal, not divestiture: the argument was that a president cannot hand a conflicted matter to someone else inside the same chain of command the way an agency employee can, because every executive action ultimately traces back to presidential authority. That argument does not reach a rule about what the President is permitted to own before taking office in the first place. A president holding no conflicting asset has nothing to recuse from.

The standing wall around the Emoluments Clauses

The Foreign Emoluments Clause bars a federal officeholder from accepting anything of value from a foreign state without congressional consent. The Domestic Emoluments Clause bars the President from receiving anything beyond a fixed salary from the federal government or the states. Neither clause has produced a merits ruling against a sitting president. Blumenthal v. Trump, brought by more than 200 members of Congress, was dismissed by the D.C. Circuit in February 2020 for lack of standing. CREW v. Trump and a companion suit brought by the District of Columbia and Maryland were vacated as moot by the Supreme Court in January 2021 once Trump left office, ending the litigation before any court reached the underlying question. When Qatar offered an estimated $400 million jet in May 2025, the pattern repeated: the Justice Department's Office of Legal Counsel produced a memo concluding the gift was legal, the House passed only a non-binding resolution asking for compliance, and the one active lawsuit sought the OLC memo itself under the Freedom of Information Act rather than a ruling on the gift.

A statutory cause of action closes part of that gap, but naming a plaintiff is not the same as supplying an injury, and Spokeo v. Robins and TransUnion v. Ramirez mean a bare statutory violation, without a concrete injury behind it, still cannot get a case into federal court no matter who Congress designates to sue. The Comptroller General has no personal financial stake in a president's foreign business dealings, and neither did the members of Congress in Blumenthal or the District of Columbia and Maryland in CREW, which is exactly why "an institutional plaintiff instead of a private one" does not by itself solve the standing problem those suits ran into. The injury has to be the government's own, not the plaintiff's: the Emoluments Clauses exist to protect the government's institutional interest in an officer free of foreign financial influence, an interest the Constitution itself treats as concrete enough to warrant an outright ban rather than a disclosure requirement. Congress can assign enforcement of that governmental interest to the Comptroller General the same way the False Claims Act assigns the government's own injury from fraud to a qui tam relator, upheld in Vermont Agency of Natural Resources v. United States ex rel. Stevens (2000): the relator suffers nothing personally, but sues to vindicate an injury the government itself suffered, assigned to the relator by statute. Pairing that assignment theory with a hard reporting trigger, the statute treats an official's failure to disclose a foreign-government business relationship within a fixed window as itself inflicting the concrete informational injury FEC v. Akins (1998) recognized when a statutorily required disclosure doesn't happen, gives the Comptroller General two independent, non-frivolous injury theories to plead, not just a designation as the named plaintiff.

Standing and the separation-of-powers wall

Solving Article III standing does not by itself clear the Comptroller General to act. Bowsher v. Synar (1986) struck down a different statute for a different reason: giving the Comptroller General, an officer Congress can remove by joint resolution, the power to issue a budget directive the President had to carry out "without variation" put a congressional agent in charge of executing the law, a function the Constitution reserves to the executive branch. That is a real, separate barrier from standing, and it would defeat this proposal if the Comptroller General's role here worked the same way Gramm-Rudman-Hollings' did. It doesn't. Bowsher's own reasoning turns on the directive's self-executing character: the Comptroller General commanded, and the President had no choice but to obey, with no court in between. A statutory cause of action to seek an injunction has no such command. The Comptroller General files a claim; a federal judge, not the Comptroller General, decides whether emoluments were accepted unlawfully and whether to grant relief. That is the same posture a qui tam relator occupies under the False Claims Act, upheld in Vermont Agency: relators face zero accountability to the executive branch at all, considerably less than the Comptroller General's own removability provides, and Vermont Agency still found no separation-of-powers problem, because asking a court to adjudicate is not executing the law. This distinction has not been tested for a Comptroller General plaintiff specifically, which is the honest gap: if a future court read "seek injunctive relief for a constitutional violation" as functionally equivalent to Bowsher's self-executing directive, the assignment-of-injury theory above would need a different institutional plaintiff. An inspector general, or the Solicitor General suing on the government's own behalf, would carry the same qui tam-style injury-assignment theory without the Comptroller General's specific Bowsher history attached to it.

Designing the fix to outlast the fight over it

None of this works if it reads as a rule about one officeholder. That is why the divestiture mandate in this issue's proposals is prospective, binding whoever takes office after enactment rather than the incumbent. Congress's own 2026 stock-trading debate shows what happens without that discipline: a bipartisan bill to bar members of Congress from trading individual stocks had momentum in early 2026, until a Democratic alternative extended the same ban to the sitting President and Vice President, and Republicans read it as a bill aimed at one person rather than a rule for the office. That reading is one reason the whole effort stalled that spring. A conflicts-of-interest reform that cannot survive contact with whoever currently holds power was never built to last.